Olix Pharmaceuticals

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Iolyx Therapeutics

The company develops immunomodulatory medicines to treat ocular inflammation and autoimmune eye diseases for patients worldwide.

ONL Therapeutics

This biopharmaceutical company develops neuroprotective peptide therapies to prevent retinal cell death and preserve vision for patients with retinal diseases and conditions.

Biorchestra

The company develops RNA-based medicines and delivery systems for patients with neurodegenerative and rare central nervous system diseases.

Eloxx Pharmaceuticals

This company develops ribonucleic acid modulating medicines to treat patients with rare kidney and skin diseases caused by nonsense mutations.

Immunohelix

Immunohelix develops immune cell-specific oligonucleotide delivery systems and therapeutics for pharmaceutical companies seeking targeted treatments for immunological diseases, infections, and cancers.

Oculis

This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.